SuperGen Announces 90 Day Extension of FDA Review Date for Orathecin™ New Drug Application 29 November 2004/in 2004, News /by webadminSuperGen Announces 90 Day Extension of FDA Review Date for Orathecin™ New Drug Application /wp-content/uploads/2016/11/logo.png 0 0 webadmin /wp-content/uploads/2016/11/logo.png webadmin2004-11-29 14:20:502016-11-28 14:21:15SuperGen Announces 90 Day Extension of FDA Review Date for Orathecin™ New Drug Application
